Health knowledge made personal
Join this community!
› Share page:
Search posts:

Effect of parenteral cladribine on relapse rates in patients with relapsing forms of multiple sclerosis:

Posted Nov 17 2009 10:20pm
results of a 2-year, double-blind, placebo-controlled, crossover study
source: msif research

summary: The aim of this placebo-controlled clinical trial was to investigate the beneficial effects of cladribine given subcutaneously in people with MS compared to placebo.

The 84 patients in the study were divided into two groups. One group received cladribine first and a placebo afterwards and the other group received a placebo first and the cladribine afterwards.

The results showed that cladribine was effective in people with MS mainly because it provoked a reduction in the relapse rate.

authors: Stelmasiak Z, Solski J, Nowicki J, Jakubowska B, Ryba M, Grieb P

source: Mult Scler. 2009 Jun;15(6):767-70

weblink:click here

Have something to share with others? If so, please use the post comment link found below. Your name and email address would be appreciated but is not necessary unless you want a response from others. Thank You
Post a comment
Write a comment:

Related Searches